跳至主要内容
临床试验/DRKS00020465
DRKS00020465招募中未知

Middle Meningeal Artery Embolization Minimizes Burdensome Recurrence Rates After Newly Diagnosed Chronic Subdural Hematoma Evacuation - MEMBRANE

Klinik für Neurochirurgie BG Klinikum Unfallkrankenhaus Berlin gGmbH0 个研究点目标入组 154 人开始时间: 2021年11月18日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
154

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1.Patients who were operated on by one or more burr hole trepanations for a first manifestation of a cSDH (unihemispheric or bihemispherical) proven in computer tomography or magnetic resonance tomography
  • 2. Age =18 years
  • 3. Adequate compliance and capacity to consent
  • 4. Declaration of consent for the operation and study participation by the patient

排除标准

  • 1. Conservatively treated cSDH
  • 2. Radiological detection of an acute or subacute subdural hematoma, subarachnoid hemorrhage, intracerebral hematoma, epidural hematoma
  • 3. Surgical technique: craniotomy, craniectomy, bilateral burr hole trepanation
  • 4. Angiography cannot be performed within 72 hours after surgery
  • 5. Age <18 years
  • 6. Supervisory relationship
  • 7. Pregnancy
  • 8. No declaration of consent
  • 9. Lack of compliance
  • 10. Homozygous factor XIII deficiency with RA <10%

研究者

发起方
Klinik für Neurochirurgie BG Klinikum Unfallkrankenhaus Berlin gGmbH

相似试验

Middle Meningeal Artery Embolization Minimizes... | 临床试验